tiprankstipranks
CureVac reports Q4 revenue EUR 22.6M vs. EUR 11.7M last year
PremiumThe FlyCureVac reports Q4 revenue EUR 22.6M vs. EUR 11.7M last year
1d ago
CureVac names Thaminda Ramanayake chief business officer
PremiumThe Fly
CureVac names Thaminda Ramanayake chief business officer
1d ago
CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial
PremiumThe Fly
CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial
1d ago
CureVac’s Influenza Vaccine Shows Strong Phase 2 Results
PremiumCompany AnnouncementsCureVac’s Influenza Vaccine Shows Strong Phase 2 Results
21d ago
CureVac announces Phase 2 interim data from influenza vaccine program
PremiumThe Fly
CureVac announces Phase 2 interim data from influenza vaccine program
21d ago
CureVac announces Phase 2 interim data from COVID-19 vaccine program
PremiumThe Fly
CureVac announces Phase 2 interim data from COVID-19 vaccine program
4M ago
CVAC Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCVAC Upcoming Earnings Report: What to Expect?
6M ago
CureVac announces progress in Phase 2 COVID-19, Seasonal Flu programs
PremiumThe Fly
CureVac announces progress in Phase 2 COVID-19, Seasonal Flu programs
6M ago
CureVac initiated with a Not Rated at Goldman Sachs
PremiumThe Fly
CureVac initiated with a Not Rated at Goldman Sachs
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100